AstraZeneca Plc (AZN) Q1 2023 Earnings Call Transcript : com

AZN earnings call for the period ending March 31, 2023.

Related Keywords

Japan , Beijing , China , Qingdao , Shandong , Germany , United States , Chinese , American , James Gordon Jpmorgan , Simon Baker Redburn , Mark Purcell Morgan Stanley , Imfinzi Trx , Michael Leuchten , Peter Welford , Andrew Baum Citi , Seamus Fernandez , Peter Welford Jefferies , Emmanuel Papadakis , Mark Purcell , Pulmicort Flexhaler , Pantumor Enhertu , Sandy Barnett , Cristian Massacesi , James Gordon , Mattias Haggblom Handelsbanken , Pascal Soriot , Naresh Chouhan , Andrew Baum , Luisa Hector Berenberg , Morgan Stanley , Matthew Weston , Luisa Hector , Simon Baker , America Merrill Lynch , Seamus Fernandez Guggenheim , Tim Anderson Wolfe Research Analyst , Oncology Research , Emmanuel Papadakis Deutsche Bank Analyst , Novartis , American Academy Of Neurology , Biopharmaceuticals Research , Cellular Biomedicine Group , Company Analyst , Naresh Chouhan Intron Health Analyst , Sachin Jain Bank , Astrazeneca Plc , Credit Suisse , European Commission , Deutsche Bank , Astrazeneca , Motley Fool Stock Advisor , Stock Advisor , Aradhana Sarin , Vice President , American Academy , Financial Times , Climate Leaders , Tim Anderson , Mattias Haggblom , Capital Markets , Harbour Biomed , James Quigley , Michele Sample , Wolfe Research , Redburn Partners , Handelsbanken Capital Markets , Executive Vice President , Guggenheim Partners ,